Related Experiment Video
Updated: Aug 6, 2026

An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat
Published on: May 19, 2020
Dynamic Changes and Prognostic Impact of Ischemic Mitral Regurgitation in Recurrent Myocardial Infarction
Chiharu Nishino1,2, Shun Nishino1, Akihiro Hayashida3
1Department of Cardiology, Miyazaki Medical Association Hospital Cardiovascular Center.
Background:
The prognostic impact of ischemic mitral regurgitation (IMR) in recurrent myocardial infarction (MI) remains poorly defined. This study evaluated dynamic changes in IMR during recurrent MI and determined prognostic implications.
Methods And Results:
We retrospectively reviewed 4,091 patients who underwent primary percutaneous coronary intervention for acute MI between May 2008 and July 2022. Of these patients, 88 experienced a second MI and underwent transthoracic echocardiography at 3 time points: before recurrent MI, at onset, and at discharge. IMR severity was assessed using mean vena contracta width. Logistic regression was used to determine predictors of persistent IMR, and Cox analysis was used to evaluate 5-year adverse outcomes (a composite of all-cause death, heart failure hospitalization, and third MI). IMR worsened at the onset of recurrent MI and remained elevated at discharge (P<0.001). Older age, lower left ventricular ejection fraction (LVEF), and greater IMR severity at onset independently predicted persistent IMR. In multivariable Cox analysis, residual IMR (per 1-mm increase: hazard ratio [HR] 1.22; 95% confidence interval [CI] 1.08-1.38) and reduced LVEF (per 1% decrease: HR 0.95; 95% CI 0.92-0.98) were independently associated with a higher risk of 5-year adverse events.
Conclusions:
IMR changes dynamically during recurrent MI and often persists despite acute treatment. Residual IMR and reduced LVEF predicted long-term adverse outcomes, highlighting the importance of residual IMR assessment for risk stratification.
Insights
Ischemic mitral regurgitation (IMR) worsens during recurrent myocardial infarction (MI) and often persists. Persistent IMR and reduced left ventricular ejection fraction (LVEF) predict poor long-term outcomes after MI.
Area of Science:
- Cardiology
- Cardiovascular Research
- Interventional Cardiology
Background:
- Prognostic impact of ischemic mitral regurgitation (IMR) in recurrent myocardial infarction (MI) is not well understood.
- Dynamic changes in IMR during recurrent MI require further investigation.
- Assessing IMR in the context of recurrent MI is crucial for patient outcomes.
Purpose of the Study:
- To evaluate dynamic changes in IMR during recurrent MI.
- To determine the prognostic implications of IMR in patients experiencing a second MI.
- To identify predictors of persistent IMR and long-term adverse events.
Main Methods:
- Retrospective review of 4,091 patients undergoing primary percutaneous coronary intervention for acute MI.
- Analysis of 88 patients with recurrent MI, with echocardiography at three time points.
- Assessment of IMR severity using mean vena contracta width; logistic and Cox regression analyses for predictors and outcomes.
Main Results:
- IMR severity worsened at the onset of recurrent MI and remained elevated at discharge.
- Older age, lower left ventricular ejection fraction (LVEF), and greater IMR severity at onset predicted persistent IMR.
- Residual IMR and reduced LVEF were independently associated with a higher risk of 5-year adverse events (death, heart failure hospitalization, third MI).
Conclusions:
- IMR exhibits dynamic changes during recurrent MI and frequently persists despite treatment.
- Residual IMR and reduced LVEF are significant predictors of long-term adverse outcomes.
- Assessment of residual IMR is vital for risk stratification in patients with recurrent MI.
More Related Videos
08:31A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
11:50High-frequency High-resolution Echocardiography: First Evidence on Non-invasive Repeated Measure of Myocardial Strain, Contractility, and Mitral Regurgitation in the Ischemia-reperfused Murine Heart
Published on: July 9, 2010
Related Concept Videos
Mitral Regurgitation I: Introduction
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation III: Medical Management
Mitral Regurgitation IV: Nursing Management
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Valve Prolapse I: Introduction